James E. Flynn 13D/13G Filings for Intersect ENT, Inc. (XENT)

James E. Flynn 13D and 13G filings for Intersect ENT, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
12:35 pm
Purchase
2020-12-3113GIntersect ENT, Inc.
XENT
James E. Flynn4,438,213
4.985%
1,641,180increase
(+58.68%)
Filing
2020-02-13
4:17 pm
Purchase
2019-12-3113GIntersect ENT, Inc.
XENT
James E. Flynn2,797,033
8.880%
718,658increase
(+34.58%)
Filing